Ignite Creation Date:
2024-05-06 @ 4:36 PM
Last Modification Date:
2024-10-26 @ 2:12 PM
Study NCT ID:
NCT05032183
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-03
First Post:
2021-08-23
Brief Title:
Tagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Refractory T Acute Lymphoblastic Leukemia |
| Recurrent Adult Lymphoblastic Lymphoma |
| Recurrent B Acute Lymphoblastic Leukemia |
| Recurrent T Acute Lymphoblastic Leukemia |
| Refractory B Acute Lymphoblastic Leukemia |
| Refractory Lymphoblastic Lymphoma |
Keywords: